Reduction of oxidative stress: A new indication for acetylsalicylic acid in coronary artery bypass surgery

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 6, 2013, Pages 1163-1164

  Diehl, Philipp ^a   Olivier, Christoph ^a   Bode, Christoph ^a   Moser, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acetylsalicylic acid; Coronary artery bypass grafting; Inflammation; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; OXYGEN RADICAL; PRASUGREL; TICAGRELOR; TROPONIN T;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; GRAFT PATENCY; HEART MUSCLE INJURY; HUMAN; INFLAMMATION; NOTE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL PATIENT; THROMBOCYTE AGGREGATION; DRUG EFFECT; FEMALE; MALE; METHODOLOGY; DRUG EFFECTS; PROCEDURES;

ACETYLSALICYLIC ACID; CORONARY ARTERY BYPASS GRAFTING; INFLAMMATION; OXIDATIVE STRESS;

ASPIRIN; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INFLAMMATION; MALE; OXIDATIVE STRESS;

EID: 84878184287     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs614     Document Type: Note

References (10)

1. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001-2008. JAMA 2011;305:1769-76.
2. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-II: maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159-68.
3. Miceli A, Duggan SM, Aresu G, de Siena PM, Romeo F, Glauber M et al. Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 2013;43:722-8.
4. Diehl P, Olivier C, Halscheid C, Helbing T, Bode C, Moser M. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes. Basic Res Cardiol 2010;105:379-87.
5. Wu R, Lamontagne D, de Champlain J. Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 2002;105:387-92.
6. van Boven WJ, Gerritsen WB, Driessen AH, Morshuis WJ, Waanders FG, Haas FJ et al. Myocardial oxidative stress, and cell injury comparing three different techniques for coronary artery bypass grafting. Eur J Cardiothorac Surg 2008;34:969-75.
7. Berg K, Langaas M, Ericsson M, Pleym H, Basu S, Nordrum IS et al. Acetylsalicylic acid treatment until surgery reduces oxidative stress and inflammation in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 2013;43:1167-76.
8. Balciunas M, Bagdonaite L, Samalavicius R, Griskevicius L, Vuylsteke A. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study. Ann Card Anaesth 2009;12:127-32.
9. Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011;57: 672-84.
10. Smith PK, Goodnough LT, Levy JH, Poston RS, Short MA, Weerakkody GJ et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. J Am Coll Cardiol 2012;60:388-96.